Searched for
INDIA PHARMACEUTICAL SCANDAL
Cough syrup-linked deaths: Do you realise what dent it caused to country's image, SC asks pharma firmThe Supreme Court questioned a pharmaceutical firm regarding cough syrups linked to the deaths of over 18 children in Uzbekistan. The court...- ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
- Drug deals: 8 doctors, 50+ pharma firms under microscope for unauthorised trials at Ahmedabad hospitalA preliminary inquiry revealed that eight doctors and an associate professor at V S Hospital in Ahmedabad allegedly collaborated with over ...
- US FDA uncovers fresh faults at India's second-biggest drugmaker Aurobindo PharmaAuditors uncovered “deficient” manufacturing equipment cleaning and storage controls during a visit last month to an Aurobindo Pharma Ltd. ...
- View: India's drug industry needs a major overhaulDespite campaigns for regulatory reform since a corruption and fraud scandal in 2013, India's Central Drugs Standard Control Organisation r...
- India needs a national drug recall law without further delay. Here's whyThe syrup was found by WHO to be adulterated with diethylene glycol (DEG) and ethylene glycol. Such adulteration is not uncommon in India. ...
- Gambia cough syrup deaths: India launches probe, awaits evidence from WHO; latest developmentsThe World Health Organisation (WHO) on Wednesday warned that four "contaminated" and "substandard" cough syrups allegedly produced by Maide...
- Sun Pharma’s best day in 16 months boosts July show of pharma fundsNet asset values of ICICI Prudential Healthcare and Diagnostics, Nippon India Pharma Fund, Tata India Pharma & Healthcare Fund, UTI Healthc...
- How a kidnapping case blew the lid off l'affaire CronjeIn 1999, Delhi Police's anti-extortion cell was probing the sensational kidnapping of the scion of a Karol Bagh-based pharmaceutical busine...
- Recalling defective vaccines will deal heavy blow to China's drug exports: expertsChina initiated protocols on Tuesday to recall fake rabies vaccines sold in other countries and regions amid the recent vaccine scandal.
- 30,000 sign petition in support of Indian professionals denied UK visasThe minister, who revealed that at least 300 such cases were currently undergoing a judicial review appeals process and being looked at by ...
- Ranbaxy whistleblower Dinesh Thakur may set up patient advocacy groupThakur is considering plans to set up a patient advocacy group that will aim to increase transparency and accountability among drug makers ...
- Manmohan Singh bidding adieu to office in diligent styleIf the election results match the exit polls reported so far, officials expect Singh to be considered for the post of leader of the Opposit...
- India to showcase drugmaking facilities to global regulatorsIndia is showcasing its best pharmaceutical manufacturing facilities to regulators from emerging economies to counter adverse publicity.
- Ranbaxy drugs fine, say WHO, UK regulatorUK has issued a statement clarifying that they have found no evidence that any of Ranbaxy’s products in the UK market “are or have been of ...
- Infrastructure & Consumerism have long term potential in India: Gautam PrakashGautam Prakash, Founder & Managing Director, Monsoon Capital in an interview with ET Now talks about emerging economies like India and Chin...
- PM, Advani, Tata, Ambanis among India's most powerfulManmohan Singh, L K Advani, Ambanis, Ratan Tata and Tendulkar have been named among the 50 most powerful people in India by BusinessWeek. T...
- US auditor also slipped on Satyam accountsIt looks like even the auditors' auditor, Public Company Accounting Oversight Board, missed the gigantic fraud in Satyam Computers. Satyam'...
- US firm drags Sun Pharma to court on StratteraUS drug giant Eli Lilly & Co has filed a patent infringement suit against Sun Pharmaceutical Industries to prevent the latter from selling ...
- US teams up with India Inc for IPR reformsIndia holds tremendous potential for growth in knowledge-based industries like bio-technology and pharmaceutical research and development.
Load More
